30
Participants
Start Date
August 1, 2025
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
Extended-release Buprenorphine
"First 10 participants will receive XR-BUP 16mg in single-blind fashion. If at least 90% of the participants who received 16mg successfully complete induction (success defined as experiencing no BPOW),10 additional participants will receive a 24mg dose in a single blind fashion.~If at least 90% who received 24mg successfully complete induction (success defined as experiencing no BPOW), 10 additional participants will receive a 32mg dose in a single blind fashion."
Brigham and Women's Hospital, Boston
University of Utah
OTHER
Brigham and Women's Hospital
OTHER